Aptamer-Assisted DNA SELEX: Dual-Site Targeting of a Single Protein

IF 5.5 2区 医学 Q2 MATERIALS SCIENCE, BIOMATERIALS ACS Biomaterials Science & Engineering Pub Date : 2025-02-27 DOI:10.1021/acsbiomaterials.4c02053
Achut Prasad Silwal, Siddhartha Kalpa Samadhi Thennakoon, Raunak Jahan, Satya Prakash Arya, Rick Mason Postema, Hari Prasad Timilsina, Andrew Michael Reynolds, Kaytelee Brooke Kokensparger and Xiaohong Tan*, 
{"title":"Aptamer-Assisted DNA SELEX: Dual-Site Targeting of a Single Protein","authors":"Achut Prasad Silwal,&nbsp;Siddhartha Kalpa Samadhi Thennakoon,&nbsp;Raunak Jahan,&nbsp;Satya Prakash Arya,&nbsp;Rick Mason Postema,&nbsp;Hari Prasad Timilsina,&nbsp;Andrew Michael Reynolds,&nbsp;Kaytelee Brooke Kokensparger and Xiaohong Tan*,&nbsp;","doi":"10.1021/acsbiomaterials.4c02053","DOIUrl":null,"url":null,"abstract":"<p >Heterobivalent fusion aptamers that target a single protein show significant promise for studying protein–protein interactions. However, a major challenge is finding two distinct aptamers that can simultaneously recognize the same protein. In this study, we used a novel technique called Aptamer-Assisted DNA SELEX (AADS) to isolate two distinct aptamers capable of recognizing different sites on the programmed death-ligand 1 (PD-L1) protein. Initially, Aptamer 1 (P1C2) was identified by using conventional DNA SELEX targeting the PD-L1 protein. Subsequently, Aptamer 2 (P1CSC) was obtained via AADS, which was designed to bind to the PD-L1/P1C2 complex. After confirming that both aptamers could simultaneously recognize the PD-L1 protein, we engineered fusion aptamers by optimizing their orientation and linker sequences, resulting in the creation of the optimized fusion aptamer, P1CSC-T7-P1C1. Our fusion aptamer targeting PD-L1 demonstrated remarkable specificity and affinity, effectively inhibiting PD-1/PD-L1 interactions at both the protein and cellular levels. These findings highlight the potential of fusion aptamers via AADS as powerful tools for targeting the PD-L1 protein and cancer cells (A549 cells). This represents a significant advancement in aptamer-based molecular recognition and has the potential to drive innovation as a versatile method for targeting a wide range of proteins.</p>","PeriodicalId":8,"journal":{"name":"ACS Biomaterials Science & Engineering","volume":"11 8","pages":"5085–5095"},"PeriodicalIF":5.5000,"publicationDate":"2025-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Biomaterials Science & Engineering","FirstCategoryId":"5","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acsbiomaterials.4c02053","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0

Abstract

Heterobivalent fusion aptamers that target a single protein show significant promise for studying protein–protein interactions. However, a major challenge is finding two distinct aptamers that can simultaneously recognize the same protein. In this study, we used a novel technique called Aptamer-Assisted DNA SELEX (AADS) to isolate two distinct aptamers capable of recognizing different sites on the programmed death-ligand 1 (PD-L1) protein. Initially, Aptamer 1 (P1C2) was identified by using conventional DNA SELEX targeting the PD-L1 protein. Subsequently, Aptamer 2 (P1CSC) was obtained via AADS, which was designed to bind to the PD-L1/P1C2 complex. After confirming that both aptamers could simultaneously recognize the PD-L1 protein, we engineered fusion aptamers by optimizing their orientation and linker sequences, resulting in the creation of the optimized fusion aptamer, P1CSC-T7-P1C1. Our fusion aptamer targeting PD-L1 demonstrated remarkable specificity and affinity, effectively inhibiting PD-1/PD-L1 interactions at both the protein and cellular levels. These findings highlight the potential of fusion aptamers via AADS as powerful tools for targeting the PD-L1 protein and cancer cells (A549 cells). This represents a significant advancement in aptamer-based molecular recognition and has the potential to drive innovation as a versatile method for targeting a wide range of proteins.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
核酸适体辅助DNA SELEX:单蛋白的双位点靶向。
靶向单一蛋白的异二价融合适体在研究蛋白与蛋白相互作用方面具有重要的前景。然而,一个主要的挑战是找到两个不同的适体,可以同时识别相同的蛋白质。在这项研究中,我们使用了一种称为aptmer - assisted DNA SELEX (AADS)的新技术来分离两种不同的适配体,它们能够识别程序性死亡配体1 (PD-L1)蛋白上的不同位点。最初,Aptamer 1 (P1C2)是通过针对PD-L1蛋白的传统DNA SELEX鉴定的。随后,通过AADS获得Aptamer 2 (P1CSC),该Aptamer 2被设计为与PD-L1/P1C2复合物结合。在确认这两个适体可以同时识别PD-L1蛋白后,我们通过优化它们的取向和连接子序列来设计融合适体,从而创建了优化的融合适体P1CSC-T7-P1C1。我们的融合适体靶向PD-L1显示出显著的特异性和亲和力,在蛋白质和细胞水平上有效抑制PD-1/PD-L1相互作用。这些发现强调了通过AADS融合适体作为靶向PD-L1蛋白和癌细胞(A549细胞)的强大工具的潜力。这代表了基于适配体的分子识别的重大进步,并有可能推动创新,成为一种针对多种蛋白质的通用方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
ACS Biomaterials Science & Engineering
ACS Biomaterials Science & Engineering Materials Science-Biomaterials
CiteScore
10.30
自引率
3.40%
发文量
413
期刊介绍: ACS Biomaterials Science & Engineering is the leading journal in the field of biomaterials, serving as an international forum for publishing cutting-edge research and innovative ideas on a broad range of topics: Applications and Health – implantable tissues and devices, prosthesis, health risks, toxicology Bio-interactions and Bio-compatibility – material-biology interactions, chemical/morphological/structural communication, mechanobiology, signaling and biological responses, immuno-engineering, calcification, coatings, corrosion and degradation of biomaterials and devices, biophysical regulation of cell functions Characterization, Synthesis, and Modification – new biomaterials, bioinspired and biomimetic approaches to biomaterials, exploiting structural hierarchy and architectural control, combinatorial strategies for biomaterials discovery, genetic biomaterials design, synthetic biology, new composite systems, bionics, polymer synthesis Controlled Release and Delivery Systems – biomaterial-based drug and gene delivery, bio-responsive delivery of regulatory molecules, pharmaceutical engineering Healthcare Advances – clinical translation, regulatory issues, patient safety, emerging trends Imaging and Diagnostics – imaging agents and probes, theranostics, biosensors, monitoring Manufacturing and Technology – 3D printing, inks, organ-on-a-chip, bioreactor/perfusion systems, microdevices, BioMEMS, optics and electronics interfaces with biomaterials, systems integration Modeling and Informatics Tools – scaling methods to guide biomaterial design, predictive algorithms for structure-function, biomechanics, integrating bioinformatics with biomaterials discovery, metabolomics in the context of biomaterials Tissue Engineering and Regenerative Medicine – basic and applied studies, cell therapies, scaffolds, vascularization, bioartificial organs, transplantation and functionality, cellular agriculture
期刊最新文献
A Rat Model of Lateral Ankle Sprain Induced by Manual Manipulation, with Controlled Force and Angle: An Experimental Study. Multi-Stimulus-Responsive Smart Hydrogels: Response Mechanisms, Synthesis Strategies, and Frontiers in Biomedical Applications. Advances in 3D Bioprinting of Functional Skeletal Muscle Constructs: Focus on Preclinical Models and Evaluation Strategies. Engineering Human Retinal Organoids and Eye-on-a-Chip Models for Degenerative Eye Disease. Implantation and Analysis of a Biphasic Bioinspired Osteochondral Chitosan Construct in a Large Animal Model.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1